GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (NZSE:EBO) » Definitions » Total Liabilities

Ebos Group (NZSE:EBO) Total Liabilities : NZ$4,955 Mil (As of Dec. 2023)


View and export this data going back to 1960. Start your Free Trial

What is Ebos Group Total Liabilities?

Ebos Group's Total Liabilities for the quarter that ended in Dec. 2023 was NZ$4,955 Mil.

Ebos Group's quarterly Total Liabilities increased from Dec. 2022 (NZ$4,422.90 Mil) to Jun. 2023 (NZ$4,498.50 Mil) and increased from Jun. 2023 (NZ$4,498.50 Mil) to Dec. 2023 (NZ$4,954.62 Mil).

Ebos Group's annual Total Liabilities increased from Jun. 2021 (NZ$2,733.49 Mil) to Jun. 2022 (NZ$4,560.36 Mil) but then declined from Jun. 2022 (NZ$4,560.36 Mil) to Jun. 2023 (NZ$4,498.50 Mil).


Ebos Group Total Liabilities Historical Data

The historical data trend for Ebos Group's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group Total Liabilities Chart

Ebos Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,053.73 2,607.21 2,733.49 4,560.36 4,498.50

Ebos Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,759.77 4,560.36 4,422.90 4,498.50 4,954.62

Ebos Group Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ebos Group's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2892.647+(1295.763+16.741
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+282.125+11.225)
=4,499

Total Liabilities=Total Assets (A: Jun. 2023 )-Total Equity (A: Jun. 2023 )
=7005.151-2506.649
=4,499

Ebos Group's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2856.586+(1731.151+67.168000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+299.713+0)
=4,955

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=7468.203-2513.585
=4,955

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ebos Group Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ebos Group's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Ebos Group (NZSE:EBO) Business Description

Traded in Other Exchanges
Address
108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (NZSE:EBO) Headlines

No Headlines